Royalty Pharma Plc
RPRX
Revenue
537.27M
▼-30.71M▼-5.41%
3 Months ChangeAssets
17.66B
▲1.53B▲9.46%
3 Months ChangeLiabilities
7.90B
▲1.64B▲26.13%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001193125-24-227407
2024-08-08
Form 10-Q
ID: 0001802768-24-000045
2024-08-08
Form 8-K
ID: 0001193125-24-196475
2024-08-07
Form 8-K
ID: 0001193125-24-195397
2024-06-20
Form 8-K
ID: 0001193125-24-164004
2024-06-10
Form 8-K
ID: 0001193125-24-158417
2024-06-06
Form 8-K
ID: 0001193125-24-156183
2024-06-04
Form 8-K
ID: 0001193125-24-154347
2024-05-29
Form 8-K
ID: 0001193125-24-149338
2024-05-09
Form 10-Q
ID: 0001802768-24-000021